Biomechanical phenomenum description of gait in patients with type 2 spinocerebellar ataxia
Keywords:
type 2 spinocerebellar ataxia, biomechanical phenomenum description, ataxic gait, movement disorder.Abstract
A descriptive and cross-sectional study of 23 patients with clinical, neurological and genetic diagnosis of type 2 spinocerebellar ataxia, assisted in the Neurogenetic Service of “Dr. Juan Bruno Zayas Alfonso” Teaching General Hospital in Santiago de Cuba, was carried out from January, 2013 to December, 2015, in order to obtain a reduced group of gait spacetemporal parameters in these patients, by means of the videographic technique. A sample of 35 healthy individuals over 18 years chosen at random, was also included. Significant differences between the biomechanical phenomenum variables extracted from the evaluation of gait in sick and healthy people were observed. The method used allowed to determine that the course of the disease influences in the decrease of gait speed and increases the step width and the hip oscillations.
Downloads
References
2. Ilg W, Bastian AJ, Boesch S, Burciu RG, Celnik P, Claaben J, et al. Consensus paper: management of degenerative cerebellar disorders. Cerebellum. 2014; 13(2):248-68.
3. Cakrt O, Vyhnalek M, Slabý K, Funda T, Vuillerme N, Kolá P, et al. Balance rehabilitation therapy by tongue electrotactile biofeedback in patients with degenerative cerebellar disease. NeuroRehabilitation. 2012; 31(4):429-34.
4. Keller LJ, Bastian AJ. A home balance exercise program improves walking in people with cerebellar ataxia. NeuroRehabil Neural Repair. 2014 [citado 21 Abr 2015]; 28(8). Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/24526707
5. Broche Vázquez L, Torres Quezada M, Diaz Novo C, Pérez Bonne P, Sagaró Zamora R. Influencia de la asimetría de la marcha en el comportamiento biomecánico de las articulaciones de cadera en pacientes con prótesis transfemorales. Ingeniare. Rev Chil Ing. 2015; 23(2): 312-22.
6. Miyares OA, Vázquez BL, Novo DC, Castillo GL, Zamora SR. Análisis de la funcionabilidad de prótesis ortopédicas transfemorales. Rev Cubana Ortop Traumatol. 2011; 25(2):102-16.
7. Diaz Novo C, Alharbi S, Fox M, Ouellette E, Biden E, Tingley M, et al. The impact of technical parameters such as video sensor technology, system configuration, marker size and speed on the accuracy of motion analysis systems. Ing Mec, Tecnol Des. 2014; 5:265-71.
8. Minitab® 16.1.1. Statistical software, 2010[citado 21 Jun 2015]. Disponible en: http://www.minitab.com/uploadedfiles/documents/readme/minitab_16_readme_en.pdf
9. Human Connect, version 6 Overview [citado 21 Jun 2015]: Disponible en: http://hub.humanapi.co/docs/overview-of-human-connect
10. Morton SM, Bastian AJ. Relative contributions of balance and voluntary leg-coordination deficits to cerebellar gait ataxia. J Neurophysiol. 2003; 89(4):1844-56.
11. Palliyath S, Hallett M, Thomas SL, Lebiedowska MK. Gait in patients with cerebellar ataxia. Mov Disord.1998;13:958–64.
12. Deuschl G, Stolze H, Petersen G, Raethjen J. The gait disorder of advanced essential tremor. Brain. 2001;124:2278-86.
13. Stolze H, Klebe S, Petersen G, Raethjen J, Wenzelburger R, Witt K, et al. Typical features of cerebellar ataxic gait. J Neurol Neurosurg Psychiatry. 2002; 73:310-12.
14. Miyai I, Ito M, Hattori N, Mihara M, Hatakenaka M, Yagura H, et al. Cerebellar ataxia rehabilitation trial in degenerative cerebellar diseases. NeuroRehabil Neural Repair. 2012;26:515-3.
15. Saute Morales AJ, Donis Carvalho K, Munuera Serrano C, Genis D, Ramírez Torrez L, Mazzetti P, et al. Ataxia rating scales-psychometric profiles, natural history and their application in clinical trials. Cerebellum. 2012; 11(12):488-504.
16. Burk K, Schulz RS, Schulz BJ. Monitoring progression in Friederich ataxia (FRDA): the use of clinical scales. J Neurochem 2013; 126(1):118-24.
17. Brigita S, David EK. Base of support is not wider in chronic ataxic and unsteady patients. J Rehabil Med. 2002;34:288-92.
Published
How to Cite
Issue
Section
License
All the articles can be downloaded or read for free. The journal does not charge any amount of money to the authors for the reception, edition or the publication of the articles, making the whole process completely free. Medisan has no embargo period and it is published under the license of Creative Commons, International Non Commercial Recognition 4.0, which authorizes the copy, reproduction and the total or partial distribution of the articles in any format or platform, with the conditions of citing the source of information and not to be used for profitable purposes.